Product Information

BUDESONIDE 2 MG RECTAL FOAM is a generic product labeled by Oceanside Pharmaceuticals, priced at $9.4092 per GM under NDC 68682065803. Its NADAC has been published 58 times since Aug 28, 2024.

FDA first approved this application on Oct 7, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUDESONIDE 2 MG RECTAL FOAM

budesonide
$9.4092per GM

Strength

2 mg/1

NDC

68682065803

Classification

Generic

Dosage Form

AEROSOL, FOAM

Route

RECTAL

Effective Date

9/17/2025

Active Ingredients

BUDESONIDE

Approval Type

New Drug (NDA)

FDA Application

NDA205613

FDA Approved

10/7/2014

TE Code

AB

On Market Since

7/15/2022

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for BUDESONIDE 2 MG RECTAL FOAM has been published 58 times since Aug 28, 2024, and over the history we have for it it has risen 32.9%. The table below summarizes its recorded NADAC range and movement.

Current price$9.4092 per GM
All-time high$9.4092 (Oct 1, 2025)
All-time low$7.0795 (Aug 28, 2024)
Median price$9.1543
Average price$8.7602
Largest weekly change+6.7% (Oct 23, 2024)
Weeks tracked58
Tracking sinceAug 28, 2024

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

+32.9%

Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUDESONIDE 2 MG RECTAL FOAM?

The current National Average Drug Acquisition Cost (NADAC) for BUDESONIDE 2 MG RECTAL FOAM, manufactured by Oceanside Pharmaceuticals, is $9.4092 per GM (NDC 68682065803), effective Oct 1, 2025.

How has the price of BUDESONIDE 2 MG RECTAL FOAM changed over time?

Over the history we have for it, the NADAC for BUDESONIDE 2 MG RECTAL FOAM has risen 32.9%. It has been tracked across 58 weekly CMS publications since Aug 28, 2024.

What are the highest and lowest recorded NADAC prices for BUDESONIDE 2 MG RECTAL FOAM?

Since Aug 28, 2024, the NADAC for BUDESONIDE 2 MG RECTAL FOAM has ranged from a low of $7.0795 (Aug 28, 2024) to a high of $9.4092 (Oct 1, 2025), with a median of $9.1543 per GM.

Are there cheaper alternatives to BUDESONIDE 2 MG RECTAL FOAM?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUDESONIDE 2 MG RECTAL FOAM, is $9.3919 per GM — about 0% below BUDESONIDE 2 MG RECTAL FOAM.

Who manufactures BUDESONIDE 2 MG RECTAL FOAM?

BUDESONIDE 2 MG RECTAL FOAM (NDC 68682065803) is labeled by Oceanside Pharmaceuticals, and CMS classifies it as a generic product.